Skip to main content
Premium Trial:

Request an Annual Quote

Angus MacLeod, David Della Penta

Premium

Galapagos said this week that Angus MacLeod has joined the company's service division BioFocus as director of medicinal chemistry.

MacLeod previously worked at Merck Sharp & Dohme, most recently as senior director of medicinal chemistry, Galapagos said.


Fisher Scientific said this week that President and CEO David Della Penta will retire at the end of 2006.

He has been with Fisher since 1998. The company said additional announcements regarding his successor will be made later in the year.

 

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.